| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENOV | Common stock, par value $0.001 | +Grant/Award | $0 | +32,283 | +19.86% | $0.00 | 194,827 | Feb 27, 2023 | Direct | F1 |
| transaction | ENOV | Common stock, par value $0.001 | -Sell | -$1,063,325 | -18,917 | -9.71% | $56.21 | 175,910 | Feb 27, 2023 | Direct | F2 |
| transaction | ENOV | Common stock, par value $0.001 | +Grant/Award | $0 | +28,221 | +16.04% | $0.00 | 204,131 | Feb 28, 2023 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENOV | Employee Stock Option (right to buy) | +Grant/Award | $0 | +66,922 | $0.00 | 66,922 | Feb 28, 2023 | Common stock, par value $0.001 | 66,922 | $57.62 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Reflects the certification of the performance criteria for PRSUs previously awarded in 2020. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2021 Fiscal Year-End" table on page 45 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 28, 2022. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units. |
| F3 | This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. |
| F4 | The option vests in three equal annual installments beginning on the first anniversary of the grant date. |